PDVAC Executive summary 2020: Update on development of Enterotoxigenic E.coli (ETEC) vaccines

Virtual Consultation 4: 18 June 2020

18 June 2020
 | Meeting report
Download (311.6 kB)

Overview

2020 WHO Product Development for Vaccines Advisory Committee (PDVAC) Virtual Consultation 4: Update on development of Enterotoxigenic E.coli (ETEC) vaccines: 18 June 2020

The purpose of this session was to review the status of candidates in the pipeline, including the tools, assays and models that are available to facilitate product development. 

Objectives of the meeting:

  • To provide a status update on candidate and funding landscape for ETEC candidate vaccines
  • To evaluate the outcomes of the ETVAX® efficacy study in adult travellers and plans for the paediatric indication
  • To determine if ETEC should remain a “priority” pathogen for PDVAC and if yes, whether there are activities that WHO/PDVAC should engage in going forward

 

WHO Team
Immunization, Vaccines and Biologicals (IVB)
Editors
Product Development for Vaccines Advisory Committee (PDVAC)
Number of pages
15